251 related articles for article (PubMed ID: 14978342)
21. The role of adenosine and P2Y receptors expressed by multiple cell types in pain transmission.
Magni G; Ceruti S
Brain Res Bull; 2019 Sep; 151():132-143. PubMed ID: 30797817
[TBL] [Abstract][Full Text] [Related]
22. Purinergic signalling: pathophysiology and therapeutic potential.
Burnstock G
Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
[TBL] [Abstract][Full Text] [Related]
23. [Hetero-oligomerization and Functional Interaction between Purinergic Receptors Expressed in Platelets to Regulate Platelet Shape Change].
Suzuki T
Yakugaku Zasshi; 2015; 135(12):1335-40. PubMed ID: 26632148
[TBL] [Abstract][Full Text] [Related]
24. Sp-2-propylthio-ATP-α-B and Sp-2-propylthio-ATP-α-B,β-γ-dichloromethylene are novel potent and specific agonists of the human P2Y₁₁ receptor.
Haas M; Ben-Moshe I; Fischer B; Reiser G
Biochem Pharmacol; 2013 Sep; 86(5):645-55. PubMed ID: 23810430
[TBL] [Abstract][Full Text] [Related]
25. Extracellular purines and their receptors in immunoregulation. Review of recent advances.
Sitkovsky MV
Nihon Ika Daigaku Zasshi; 1998 Oct; 65(5):351-7. PubMed ID: 9808987
[TBL] [Abstract][Full Text] [Related]
26. Purinergic signaling in the retina: From development to disease.
Ventura ALM; Dos Santos-Rodrigues A; Mitchell CH; Faillace MP
Brain Res Bull; 2019 Sep; 151():92-108. PubMed ID: 30458250
[TBL] [Abstract][Full Text] [Related]
27. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
[TBL] [Abstract][Full Text] [Related]
28. Purinergic regulation of hypothalamopituitary functions.
Stojilkovic SS
Trends Endocrinol Metab; 2009 Nov; 20(9):460-8. PubMed ID: 19800813
[TBL] [Abstract][Full Text] [Related]
29. [Adjustment of intercellular communication via extracellular ATP in the nervous system].
Baranowska-Bosiacka I
Ann Acad Med Stetin; 2013; ():119-23. PubMed ID: 24669428
[No Abstract] [Full Text] [Related]
30. Purinergic signaling involved in Müller cell function in the mammalian retina.
Wurm A; Pannicke T; Iandiev I; Francke M; Hollborn M; Wiedemann P; Reichenbach A; Osborne NN; Bringmann A
Prog Retin Eye Res; 2011 Sep; 30(5):324-42. PubMed ID: 21689780
[TBL] [Abstract][Full Text] [Related]
31. Microglia and the Purinergic Signaling System.
Calovi S; Mut-Arbona P; Sperlágh B
Neuroscience; 2019 May; 405():137-147. PubMed ID: 30582977
[TBL] [Abstract][Full Text] [Related]
32. Purinergic inhibition of neurotransmitter release in the central nervous system.
Ribeiro JA
Pharmacol Toxicol; 1995 Nov; 77(5):299-305. PubMed ID: 8778740
[TBL] [Abstract][Full Text] [Related]
33. Signaling by purinergic receptors and channels in the pituitary gland.
Stojilkovic SS; He ML; Koshimizu TA; Balik A; Zemkova H
Mol Cell Endocrinol; 2010 Jan; 314(2):184-91. PubMed ID: 19467293
[TBL] [Abstract][Full Text] [Related]
34. Neuropharmacology of purinergic receptors in human submucous plexus: Involvement of P2X₁, P2X₂, P2X₃ channels, P2Y and A₃ metabotropic receptors in neurotransmission.
Liñán-Rico A; Wunderlich JE; Enneking JT; Tso DR; Grants I; Williams KC; Otey A; Michel K; Schemann M; Needleman B; Harzman A; Christofi FL
Neuropharmacology; 2015 Aug; 95():83-99. PubMed ID: 25724083
[TBL] [Abstract][Full Text] [Related]
35. Purinergic modulation of preBötzinger complex inspiratory rhythm in rodents: the interaction between ATP and adenosine.
Zwicker JD; Rajani V; Hahn LB; Funk GD
J Physiol; 2011 Sep; 589(Pt 18):4583-600. PubMed ID: 21788352
[TBL] [Abstract][Full Text] [Related]
36. Adenosine receptors. Roles and pharmacology.
Bruns RF
Ann N Y Acad Sci; 1990; 603():211-25; discussion 225-6. PubMed ID: 2291523
[No Abstract] [Full Text] [Related]
37. P2Y receptors: focus on structural, pharmacological and functional aspects in the brain.
Fischer W; Krügel U
Curr Med Chem; 2007; 14(23):2429-55. PubMed ID: 17979698
[TBL] [Abstract][Full Text] [Related]
38. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
Filtz TM; Li Q; Boyer JL; Nicholas RA; Harden TK
Mol Pharmacol; 1994 Jul; 46(1):8-14. PubMed ID: 8058061
[TBL] [Abstract][Full Text] [Related]
39. A molecularly identified P2Y receptor simultaneously activates phospholipase C and inhibits adenylyl cyclase and is nonselectively activated by all nucleoside triphosphates.
Boyer JL; Delaney SM; Villanueva D; Harden TK
Mol Pharmacol; 2000 Apr; 57(4):805-10. PubMed ID: 10727529
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of disease: role of purinergic signaling in the pathophysiology of bladder dysfunction.
Ruggieri MR
Nat Clin Pract Urol; 2006 Apr; 3(4):206-15. PubMed ID: 16607369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
